Skip to content

Xenon Pharmaceuticals Inc.

XENE· NasdaqCore metricsCIK 1582313

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.61%
Market cap
$4.03B
98.28M shares
Filings
806
$0.00
Q3 2026
-$110.44M
Q3 2026N/M FY25 yoy
-$120.07M
Q3 2026N/M FY25 yoy
-$275.31M
Q3 2026derivedN/M FY25 yoy
-$1.11
Q3 2026N/M FY25 yoy
$82.56M
Q3 2026+39.6% FY25 yoy
$4.03B
—
—
3.5×
-8.86%
—

Twelve months to Sep 30, 2026 · derived

Price

$40.99+2.60%+$1.04past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$7.50MFY 2025
$32.17M0FY 2013FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$7,500,000reported
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$9,434,000reported
FY 20212021-12-31$18,437,000reported
FY 20202020-12-31$32,166,000reported
FY 20192019-12-31$6,829,000reported
FY 20172017-12-31$311,000reported
FY 20162016-12-31$1,803,000reported
FY 20152015-12-31$15,577,000reported
FY 20142014-12-31$28,370,000reported
FY 20132013-12-31$27,356,000reported

Pharmaceutical preparations

Xenon Pharmaceuticals Inc. is the 180th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR